Studies in an ovarian cancer tissue model (50) and using xenografts of adenocarcinoma A549 cells (45) showed that antibody-mediated inhibition of PAPP-A activity decreased tumor growth presumably because pericellular IGF remains bound to IGFBPs leading to a reduction in free IGF in the local tumor environment. This evidence concerns the gene IGF1 and ovarian cancer.